Active Supportive Care and Symptom Management Grants

PI Name Organization - Company Title FOAsort descending
Chao, Nelson J. Duke University Patient-centered home-based hematopoietic stem cell transplantation PA-13-302
Redd, William H Icahn School Of Medicine At Mount Sinai Systematic Light Exposure for Fatigue in Stem Cell Transplant Survivors PA-13-302
Miaskowski, Christine A. University Of California, San Francisco Impact of Hearing Loss and Tinnitus in Cancer Survivors PA-16-160
Hui, David University Of Tx Md Anderson Can Ctr A Randomized Controlled Trial of Dexamethasone for Dyspnea in Cancer Patients PA-16-160
Raizen, David Menassah University Of Pennsylvania Effect of Radiation Therapy on Sleepiness and Activity in Prostate Cancer Patients PA-16-258
Romero-Sandoval, E. Alfonso Wake Forest University Health Sciences IRE1a-XBP1 Signaling as a Driver of Chemotherapy-Induced Peripheral Neuropathy PA-16-258
Barlow, Linda A University Of Colorado Denver Use of lingual organoids to screen for the impact of targeted cancer therapies on taste bud renewal PA-16-258
Sherman, Larry S Oregon Health & Science University Hyaluron as a regulator of chemotherapy-induced changes in neurogenesis PA-16-258
Sorror, Mohamed Fred Hutchinson Cancer Research Center Novel Intervention Approaches to Alleviate Allogeneic Transplant-Related Morbidity and Mortality PA-17-018
Mohile, Supriya G University Of Rochester Sarcopenia and Treatment Tolerability in Older Patients with Advanced Cancer PA-18-591
Sanft, Tara B Yale University A randomized trial of lifestyle guidelines on breast cancer biomarkers and treatment adherence PAR-16-122
Hui, David University Of Tx Md Anderson Can Ctr Efficacy and Safety of Rapid-Onset Opioids for Exertional Dyspnea in Cancer Patients PAR-18-559
Krause, Diane S Yale University "Exploration of Human Parathyroid Cellular Organization and Function" PAR-19-356
Gray, Robert J Dana-Farber Cancer Inst Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV) RFA-CA-17-052
Rogatko, Andre Cedars-Sinai Medical Center Advancing Analysis and Interpretation ofAdverse Events and PROs in Cancer Clinical Trials RFA-CA-17-052

Pages